Treatment effect of nafamostat mesylate in patients with COVID-19 pneumonia: study protocol for a randomized controlled trial.

Moon, Kyunglan; Hong, Kyung-Wook; Bae, In-Gyu

Moon, Kyunglan; Hong, Kyung-Wook; Bae, In-Gyu.

Affiliation

Moon K; Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
Hong KW; Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
Bae IG; Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea. ttezebae@gmail.com.

Trials ; 22(1): 832, 2021 Nov 23.

Article in En | MEDLINE | ID: mdl-34814935

Subject(s)

COVID-19; Benzamidines; Guanidines/adverse effects; Humans; Hydroxychloroquine; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome

Key words

COVID-19; Nafamostat mesilate; Randomized controlled trial; Time to improvement; protocol

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Guideline Limits: Humans Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2021 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google